SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Clinical trials for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 explained in plain language.
Never miss a new study
Get alerted when new SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 trials appear
Sign up with your email to follow new studies for SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New COVID-19 vaccine trial aims to protect kids from latest variants
⭐️ VACCINE ⭐️ CompletedThis large study is testing updated mRNA vaccines designed to protect against newer Omicron variants of COVID-19 in healthy children aged 6 months to 12 years. Over 4,000 participants will receive one or more doses depending on their age and vaccination history. Researchers are m…
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Phase: PHASE3 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 08, 2026 00:03 UTC
-
Face-Down therapy could save COVID patients who refuse ventilators
Symptom relief CompletedThis study looked at whether lying face down (prone positioning) helps hospitalized COVID-19 patients who have low oxygen levels but are not candidates for breathing machines. About 596 adults took part. The goal was to see if this simple position change could lower the chance of…
Matched conditions: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC